2020 annual financial data
INmune Bio 2020 Operating margin
INmune Bio 2020 operating margin with verified reported values.
Direct answer
Operating margin was -112,016.09%.
Operating income was -12,227,676 USD and net income was -12,099,159 USD.
Operating cash flow was -8,943,646 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,916 USD
- Operating income
- -12,227,676 USD
- Net income
- -12,099,159 USD
- Operating cash flow
- -8,943,646 USD